Teva Sells $586M in Generic Drugs to Impax

Jun 22, 2016

Reuters

According to a Reuters article, Impax Laboratories Inc. agreed to acquire a portfolio of generic drugs from Teva Pharmaceutical Industries Ltd. and Allergan Plc for about $586 million.

The deal is said to be part of the divestiture process mandated by the FTC in relation to Teva's acquisition of Allergan's generics business for $40.5 billion, the story said.

Impax said it will also take back from Teva rights to a generic version of Concerta, an ADHD drug made by Johnson & Johnson.

Read the complete article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments